Pharma

SPOTLIGHT: Is the NHS really cutting drug spending by 10%?

U.K. officials are pooh-poohing reports that they intend to cut drug spending by 10 percent with a new pharma contract now under negotiation. Report

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

by Kyle Blankenship Jan 27, 2020 10:30am

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

by Eric Palmer Jan 27, 2020 11:33am

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.

by Angus Liu Jan 27, 2020 11:42am